1例非住院的新型冠状病毒肺炎患者发生ST段抬高型急性心肌梗死：经皮冠状动脉介入治疗
A Case of ST-Elevation Acute Myocardial Infarction in a Nonhospitalized Patient with SARS-CoV-2 Pneumonia: Treatment with Primary Percutaneous Coronary Intervention.
作者信息
Shimai Ryosuke, Ouchi Shohei, Miyazaki Tetsuro, Hirabayashi Koji, Abe Hiroshi, Yabe Kosuke, Maki Masaaki, Isogai Hiroyuki, Wada Takeshi, Ozaki Dai, Odagiri Fuminori, Hiki Makoto, Yaginuma Kenji, Yokoyama Ken, Tokano Takashi, Minamino Tohru
机构信息
Department of Cardiology Juntendo Urayasu Hospital Urayasu Japan.
Department of Cardiovascular Biology and Medicine Juntendo University School of Medicine Bunkyo-ku Japan.
出版信息
Clin Case Rep. 2021 Sep 15;9(9):e04785. doi: 10.1002/ccr3.4785. eCollection 2021 Sep.
Abstract
We experienced a case of primary percutaneous coronary intervention for ST-elevation myocardial infarction (STEMI) with coronavirus disease 2019 (COVID-19) using appropriate infection prevention protocol. However, recanalization was difficult due to severe coagulopathy. Further researches are needed to clarify optimal treatment for STEMI in patients with COVID-19.
摘要
我们遇到了一例使用适当感染预防方案对患有2019冠状病毒病（COVID-19）的ST段抬高型心肌梗死（STEMI）患者进行的初次经皮冠状动脉介入治疗。然而，由于严重的凝血病，再灌注很困难。需要进一步研究以明确COVID-19患者STEMI的最佳治疗方法。
相似文献
1
A Case of ST-Elevation Acute Myocardial Infarction in a Nonhospitalized Patient with SARS-CoV-2 Pneumonia: Treatment with Primary Percutaneous Coronary Intervention.1例非住院的新型冠状病毒肺炎患者发生ST段抬高型急性心肌梗死：经皮冠状动脉介入治疗
Clin Case Rep. 2021 Sep 15;9(9):e04785. doi: 10.1002/ccr3.4785. eCollection 2021 Sep.
2
Differences in door-to-balloon time and outcomes in SARS-CoV-2-positive ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: A systematic review and meta-analysis.新型冠状病毒阳性 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗的门球时间和结局差异：系统评价和荟萃分析。
Medicine (Baltimore). 2023 Oct 13;102(41):e35612. doi: 10.1097/MD.0000000000035612.
3
Patient and Provider Risk in Managing ST-Elevation Myocardial Infarction During the COVID-19 Pandemic: A Decision Analysis.在 COVID-19 大流行期间管理 ST 段抬高型心肌梗死的患者和提供者风险：决策分析。
Circ Cardiovasc Interv. 2020 Nov;13(11):e010027. doi: 10.1161/CIRCINTERVENTIONS.120.010027. Epub 2020 Nov 10.
4
High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction.COVID-19 患者中 ST 段抬高型心肌梗死血栓负荷高。
J Am Coll Cardiol. 2020 Sep 8;76(10):1168-1176. doi: 10.1016/j.jacc.2020.07.022. Epub 2020 Jul 14.
5
ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub.COVID-19 大流行期间的 ST 段抬高型心肌梗死：区域性公共服务医疗中心的观察结果。
Circ Cardiovasc Interv. 2020 Aug;13(8):e009413. doi: 10.1161/CIRCINTERVENTIONS.120.009413. Epub 2020 Aug 14.
6
Impact of SARS-CoV-2 pandemic on ST-elevation myocardial infarction admissions and outcomes in a Portuguese primary percutaneous coronary intervention center: Preliminary Data.新型冠状病毒肺炎大流行对葡萄牙经皮冠状动脉介入治疗中心 ST 段抬高型心肌梗死患者入院和结局的影响：初步数据。
Rev Port Cardiol (Engl Ed). 2021 Jul;40(7):465-471. doi: 10.1016/j.repce.2021.07.014.
7
Angiographic and clinical outcome of SARS-CoV-2 positive patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: A collaborative, individual patient data meta-analysis of six registry-based studies.SARS-CoV-2 阳性行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者的血管造影和临床结局：六项基于注册研究的协作、个体患者数据荟萃分析。
Eur J Intern Med. 2022 Nov;105:69-76. doi: 10.1016/j.ejim.2022.08.021. Epub 2022 Aug 18.
8
orth merican OVID-19 ST-Segment-Elevation yocardial nfarction (NACMI) registry: Rationale, design, and implications.美国 OVID-19 段抬高型心肌梗死（NACMI）登记研究：原理、设计和意义。
Am Heart J. 2020 Sep;227:11-18. doi: 10.1016/j.ahj.2020.05.006. Epub 2020 May 16.
9
Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction.COVID-19 对 ST 段抬高型心肌梗死经皮冠状动脉介入治疗的影响。
Heart. 2020 Dec;106(23):1805-1811. doi: 10.1136/heartjnl-2020-317650. Epub 2020 Aug 31.
10
Transcatheter aspiration of a thrombus and percutaneous transluminal coronary recanalization for ST-segment elevation myocardial infarction related to coronavirus disease 2019.经导管血栓抽吸术及经皮腔内冠状动脉再通术治疗与2019冠状病毒病相关的ST段抬高型心肌梗死
J Cardiol Cases. 2022 Jun;25(6):373-376. doi: 10.1016/j.jccase.2021.12.013. Epub 2022 Jan 12.
本文引用的文献
1
Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients.日本新冠肺炎患者中抗新型冠状病毒2抗体的血清流行率。
PLoS One. 2021 Apr 6;16(4):e0249449. doi: 10.1371/journal.pone.0249449. eCollection 2021.
2
Inferior Wall Myocardial Infarction in Severe COVID-19 Infection: A Case Report.重症新型冠状病毒肺炎感染合并下壁心肌梗死：一例报告
Am J Case Rep. 2020 Sep 28;21:e926101. doi: 10.12659/AJCR.926101.
3
Acute myocardial infarction and large coronary thrombosis in a patient with COVID-19.COVID-19 患者的急性心肌梗死和大冠状动脉血栓形成。
Catheter Cardiovasc Interv. 2021 Feb 1;97(2):272-277. doi: 10.1002/ccd.29179. Epub 2020 Aug 7.
4
Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: current literature review.新冠病毒肺炎中纤维蛋白原和D-二聚体的变化及抗凝建议：当前文献综述
Rev Assoc Med Bras (1992). 2020 Jun;66(6):842-848. doi: 10.1590/1806-9282.66.6.842. Epub 2020 Jul 20.
5
A Case of COVID-19 with Acute Myocardial Infarction and Cardiogenic Shock.一例伴有急性心肌梗死和心源性休克的 COVID-19 病例。
J Korean Med Sci. 2020 Jul 13;35(27):e258. doi: 10.3346/jkms.2020.35.e258.
6
COVID-19 (SARS-CoV-2) and the Heart - An Ominous Association.新型冠状病毒肺炎（严重急性呼吸综合征冠状病毒2）与心脏——一种不祥的关联。
Cardiovasc Revasc Med. 2020 Aug;21(8):946-949. doi: 10.1016/j.carrev.2020.05.009. Epub 2020 May 15.
7
COVID-19 and its implications for thrombosis and anticoagulation.新型冠状病毒肺炎及其对血栓形成和抗凝的影响。
Blood. 2020 Jun 4;135(23):2033-2040. doi: 10.1182/blood.2020006000.
8
Management of Acute Myocardial Infarction During the COVID-19 Pandemic: A Position Statement From the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP).《COVID-19 大流行期间急性心肌梗死的管理：心血管血管造影和介入学会（SCAI）、美国心脏病学会（ACC）和美国急诊医师学会（ACEP）的立场声明》
J Am Coll Cardiol. 2020 Sep 15;76(11):1375-1384. doi: 10.1016/j.jacc.2020.04.039. Epub 2020 Apr 21.
9
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).COVID-19 患者的致命结局对心血管的影响。
JAMA Cardiol. 2020 Jul 1;5(7):811-818. doi: 10.1001/jamacardio.2020.1017.
10
Plasma soluble fibrin monomer complex as a marker of coronary thrombotic events in patients with acute myocardial infarction.血浆可溶性纤维蛋白单体复合物作为急性心肌梗死患者冠状动脉血栓事件的标志物。
Tohoku J Exp Med. 2009 Sep;219(1):25-31. doi: 10.1620/tjem.219.25.
Zotero 插件